bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.10.14.758827

KDM4 inhibition alters H3K9me3 distribution and developmental responses in SETDB1-deficient embryonic stem cells

Abstract

SETDB1 contributes to histone H3 lysine 9 methylation, whereas KDM4 demethylases act on H3K9 and, for KDM4A-C, H3K36. We examined whether Setdb1 status modifies responses to the KDM4-family inhibitor QC6352 in embryonic stem cells (ESCs) and embryoid bodies (EBs). QC6352 shifted Setdb1-depleted ESC colonies toward more compact morphology and increased alkaline-phosphatase (AP) staining, but also affected Setdb1-intact cells. Separate Kdm4a, Kdm4b, and Kdm4c knockdowns identified overlapping and member-specific transcriptional responses. Factorial RNA-seq revealed broadly concordant transcriptional responses to KDM4 inhibition in Setdb1-intact and depleted ESCs, alongside a smaller subset of genes with genotype-dependent treatment effects. Within this subset, two gene modules showed attenuation or reversal of Setdb1-associated expression changes following KDM4 inhibition. ChIP-seq revealed changes in the relative distribution of H3K9me3, H3K36me3, and H3K4me3 between promoters and gene bodies following KDM4 inhibition. KDM4 inhibition altered H3K9me3 distributions across repeat families in both Setdb1-intact and depleted ESCs. QC6352 also altered EB morphology and produced transcriptional responses that differed between ESCs and EBs. These findings show that KDM4 inhibition remodels chromatin and transcription in both Setdb1-intact and depleted ESCs, with Setdb1 status influencing a subset of transcriptional responses.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Geng, R., Kidder, B. L.. 2026-10-16. KDM4 inhibition alters H3K9me3 distribution and developmental responses in SETDB1-deficient embryonic stem cells. https://doi.org/10.64898/2026.10.14.758827

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

CRISPRa-mediated activation of Tfeb in a fibril-induced alpha-synuclein aggregation model

Accumulation of misfolded alpha-synuclein (a-syn) is a key hallmark of Parkinson's disease (PD), making it a key target for novel therapeutic strategies. Here, we use a previously described screening assay to select multiple efficient single guide RNA (sgRNA) combinations targeting transcription factor EB (TFEB) for CRISPR-activation (CRISPRa) using a nuclease-deficient Staphylococcus aureus Cas9 coupled to a truncated VP64-p53-Rta (VPR) activator complex. Selected sgRNA are applied in a rat neuroblastoma in-vitro model of fibril-induced a-syn aggregation with the goal of inducing autophagy and reduce protein aggregation. We successfully induce a-syn aggregation in this model and observe a stagnation in phosphorylated a-syn (p-a-syn) compared to non-phosphorylated a-syn across treatment groups. While we achieve robust expression of Tfeb in the exogenous screening assay and at endogenous mRNA level, we did not observe proportional increase in protein expression. Additionally, we do not observe any additive effects of CRISPRa induction combined with media treatments inducing Tfeb nuclear translocation. Taken together, these findings illustrate difficulties in epigenetic induction of Tfeb using CRISPRa and highlights the need for additional studies exploring this application.

molecular biology↗

cBAF drives AR-V7 expression through regulation of transcriptional termination in castration-resistant prostate cancer

The androgen receptor splice variant AR-V7 drives resistance to androgen receptor-targeted therapies in castration-resistant prostate cancer (CRPC), but the mechanisms governing its expression remain incompletely understood. Here, we identify the canonical BAF (cBAF) chromatin remodeling complex as a selective regulator of AR-V7 expression. Pharmacologic and genetic disruption of cBAF reduced AR-V7 levels, suppressed AR-V7-dependent transcriptional programs, and impaired CRPC cell proliferation. Mechanistically, cBAF binds an intronic regulatory element downstream of AR cryptic exon 3, where it maintains chromatin accessibility, enhancer activity, and promoter-enhancer looping. cBAF loss decreases recruitment of transcription termination machinery, reduces RNA polymerase II Thr4 phosphorylation, and promotes transcriptional readthrough beyond the AR-V7 polyadenylation site. POINT-seq revealed that cBAF-dependent transcriptional termination is required for AR-V7 biogenesis and regulates termination at a subset of genes genome-wide. Together, these findings uncover a role for cBAF in chromatin-mediated control of transcriptional termination and establish this mechanism as a critical determinant of AR-V7 expression.

molecular biology↗

Stage-specific checkpoint signalling by ATM, ATR and DNA-PK safeguards oocyte genome integrity

In somatic cells, DNA double-strand breaks (DSBs) are potentially catastrophic lesions that activate phosphatidylinositol 3-kinase-related kinase (PIKK) signalling to promote DNA repair or eliminate damaged cells. During meiosis, however, DSBs are deliberately generated as essential intermediates in homologous recombination, raising the question of how DNA damage signalling distinguishes programmed recombination from genome instability. To define how PIKK signalling is adapted to these distinct contexts, we resolved the function of the three PIKKs ATM, ATR and DNA-PK in physiological meiotic recombination and the response to postnatal DNA damage in mouse oocytes. Following postnatal irradiation, ATM functions as the dominant response kinase, with ATR and DNA-PK acting redundantly to eliminate damaged oocytes. In contrast, meiotic surveillance is mediated by ATR, with ATR removal rescuing oocyte loss in response to asynapsis and, independently, to persistent meiotic DSBs. Our findings demonstrate that DNA damage signalling is developmentally reconfigured during oogenesis and highlight distinct pathways of oocyte elimination that may ultimately inform strategies to maintain the ovarian reserve in mammals.

molecular biology↗